Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
lirilumab (BMS-986015)
i
Other names:
BMS-986015, IPH 2102, NN 1975, IPH2102, IPH-21, anti-KIR (1-7F9), IPH 21, BMS 986015, NN1975, ONO4483, NN-1975, ONO 4483, ONO-4483, LIRI, IPH-2102, BMS986015
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
BMS, Innate, Ono Pharmaceutical
Drug class:
KIR receptor antagonist
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.